Innate immunity is a foundational field in immunology, critical for understanding how organisms sense and respond to danger, be it pathogens or sterile ...
A major discovery by Australian scientists that will lead to a new treatment for auto-immune diseases such as lupus or ...
CERo Therapeutics Holdings, Inc. (OTCQB: CERO) ('CERo” or the 'Company”), an innovative cellular immunotherapy company ...
Persistent inflammation may influence neurodegeneration through microglial activation, yet evidence remains hypothesis driven ...
Non-communicable diseases such as diabetes, obesity, and metabolic syndrome are rising globally, while infectious diseases, ...
HCB101, a novel Fc-based anti-SIRPα-CD47 fusion protein, has received orphan drug designation (ODD) from the FDA for the ...
Miles Andrews, BSc (Hons), BMBS (Hons), FRACP, PhD, Medical Oncologist and Senior Research Fellow at the Alfred Hospital and Monash University, Melbourne, Australia; co-author of the NADINA study.
A genetics‑guided drug, compound 6, targets CARD9 to subtly calm gut inflammation in Crohn’s disease, pointing to safer, longer‑lasting, precision treatments.
Even then, it only takes one sperm to fertilise an egg, with only around 200–500 sperm typically surviving the journey to reach it. Added to that, it turns out that a woman's uterus can actually taste ...
Nucleic acids are emerging as a third generation of pharmaceuticals following the clinical accomplishments of small-molecule drugs and biologics like proteins and monoclonal antibody (mAb) therapies.
A combination immunotherapy approach using Ampligen (rintatolimod) and Imfinzi (durvalumab) showed clinical activity for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results